ImmuneBiotech Medical Sweden AB is a pharmaceutical company based in Lund that specializes in the development of therapeutically effective probiotics. The company focuses on creating products designed with pharmaceutical precision, emphasizing health-inspired and nature-derived solutions. Their first ImmuneBiotic product, GutMagnific®, represents their commitment to advancing gut health through innovative probiotic technology.
The company engages in ongoing research to enhance the efficacy and application of probiotics, aiming to contribute to the broader field of gut health and immune support. ImmuneBiotech Medical Sweden AB also offers opportunities for partnerships, reflecting its collaborative approach to innovation in the pharmaceutical sector. Regular updates about their research and product developments are provided through a dedicated news section, ensuring that stakeholders are informed about the latest advancements.